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Abstract
Noninvasive methods are needed to explore the heterogeneous tumor microenvironment and its
modulation by therapy. Hybrid PET/MRI systems are being developed for small-animal and
clinical use. The advantage of these integrated systems depends on their ability to provide MR
images that are spatially coincident with simultaneously acquired PET images, allowing combined
functional MRI and PET studies of intratissue heterogeneity. Although much effort has been
devoted to developing this new technology, the issue of quantitative and spatial fidelity of PET
images from hybrid PET/MRI systems to the tissues imaged has received little attention. Here, we
evaluated the ability of a first-generation, small-animal MRI-compatible PET scanner to
accurately depict heterogeneous patterns of radiotracer uptake in tumors.
Methods—Quantitative imaging characteristics of the MRI-compatible PET (PET/MRI) scanner
were evaluated with phantoms using calibration coefficients derived from a mouse-sized linearity
phantom. PET performance was compared with a commercial small-animal PET system and
autoradiography in tumor-bearing mice. Pixel and structure-based similarity metrics were used to
evaluate image concordance among modalities. Feasibility of simultaneous PET/MRI functional
imaging of tumors was explored by following 64Cu-labeled antibody uptake in relation to
diffusion MRI using cooccurrence matrix analysis.
Results—The PET/MRI scanner showed stable and linear response. Activity concentration
recovery values (measured and true activity concentration) calculated for 4-mm-diameter rods
within linearity and uniform activity rod phantoms were near unity (0.97 ± 0.06 and 1.03 ± 0.03,
respectively). Intratumoral uptake patterns for both 18F-FDG and a 64Cu-antibody acquired using
the PET/MRI scanner and small-animal PET were highly correlated with autoradiography (r >
0.99) and with each other (r = 0.97 ± 0.01). On the basis of these data, we performed a preliminary
study comparing diffusion MRI and radiolabeled antibody uptake patterns over time and
visualized movement of antibodies from the vascular space into the tumor mass.
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Conclusion—The MRI-compatible PET scanner provided tumor images that were quantitatively
accurate and spatially concordant with autoradiography and the small-animal PET examination.
Cooccurrence matrix approaches enabled effective analysis of multimodal image sets. These
observations confirm the ability of the current simultaneous PET/MRI system to provide accurate
observations of intratumoral function and serve as a benchmark for future evaluations of hybrid
instrumentation.
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The tumor microenvironment greatly affects the efficacy of cancer treatment (1). Factors
such as heterogeneous perfusion and subpopulations of cells within tumors affect tumor
progression and response to therapy. Investigations of these factors usually involve
measurements at a whole-tumor level (e.g., size) and tissue sampling for histologic or
biochemical assays. Noninvasive imaging complements these studies by providing intact
tissue information at multiple time points in the same individual (2).
The utility of multimodal imaging is well demonstrated in cancer research (3). Advances in
hybrid PET/MRI systems (4) show particular promise for understanding the heterogeneous
nature of the tumor microenvironment. For example, spatially and temporally matched,
high-resolution anatomic and functional information such as the perfusion status (5), cellular
density (6), and metabolic status of specific tissue regions acquired with MRI can enhance
the interpretation of functional data provided by PET (e.g., oxygenation (7), cellular
proliferation (8), and receptor expression (9)) and vice versa.
Conventional PET image analysis focuses on regions of interest (ROIs) encompassing whole
tumors, with some studies omitting obvious necrotic regions during analysis (6). Efforts to
improve the spatial resolution of reconstructed PET images (10) and availability of
coregistered PET and MR images have engendered interest in understanding the
heterogeneity of radionuclide uptake observed with PET. For example, a recent clinical
study by Metz et al. examined heterogeneity of tumor perfusion using MRI and correlated it
with PET studies of integrin expression and tumor metabolism (11). Similarly, Cho et al.
compared MRI measures of tumor perfusion with uptake of the PET hypoxia tracer 18F-
fluoromisonidazole within rat tumor xenografts (7).
Correct interpretation of PET images, especially within regions of heterogeneous tracer
uptake, requires that fidelity be verified between these images and actual tissue activity
concentration patterns. Characterization of PET instrumentation usually entails measuring a
standard set of metrics in a variety of phantoms (12), followed by gross in vivo verification.
Although this approach examines the general performance of the scanner, simple geometric
patterns of phantoms may be insufficient to predict in vivo performance. To validate the
heterogeneous spatial patterns seen in PET images, one needs to compare these images with
a gold standard, such as quantitative autoradiography (QAR) (13).
We have evaluated the image quality of a first-generation MRI-compatible PET scanner
(PET/MRI scanner) (14). Previous reports used standard metrics to assess the performance
characteristics of the scanner (15) and its ability to function within the integrated PET/MRI
environment (16). Here, we examined the image fidelity of the PET/MRI scanner and its
ability to quantify heterogeneous uptake patterns in mice, compared with QAR and a
commercial small-animal PET system. Phantoms were used to evaluate the quantitative
capability of the PET/MRI scanner. Next, the 3 systems were used to image patterns of 18F-
FDG and 64Cu-antibody uptake within mouse tumor xenografts. Finally, a preliminary,
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simultaneous in vivo diffusion MRI/radiolabeled antibody PET study was performed, and a
cooccurrence matrix method was applied to analyze the bimodal dataset.
MATERIALS AND METHODS
MRI-Compatible PET Scanner
The PET/MRI scanner being evaluated has been described in detail (14). The system fits in a
7-T MRI system run using PARA-VISION4 (Bruker Biospin). PET data were acquired
using custom software. PET/MRI data were collected with an energy window of 350–650
keV. No attenuation, random coincidence, scatter, or dead-time corrections were applied to
PET/MRI datasets (all data were collected at counting rates low enough to avoid significant
effects from dead time). Images were reconstructed with a 3-dimensional maximum a
posteriori (MAP) algorithm (30 iterations, β = 1 × 10−5) (17). Detector sensitivity
normalization was incorporated into the forward model in MAP reconstruction. The field of
view (FOV) of reconstructed PET/MRI scanner images was 35.4 × 35.4 × 12.8 mm. Image
matrix dimensions were 128 × 128 × 17, and voxel size was 0.28 × 0.28 × 0.75 mm. The
average spatial resolution of the scanner (mean of values measured at off-axis distances of 0,
5, and 10 mm using filtered backprojection reconstructed images) was 1.5 mm (15).
Phantom Studies
We measured the linearity and uniformity of reconstructed image intensities from the PET/
MRI scanner. A linearity phantom was constructed by evenly spacing four 1-mL syringes
(Becton Dickinson; inner diameter, 4 mm) on the inner surface of a 50-mL Falcon tube
(diameter, 30 mm [Becton Dickinson]; Supplemental Fig. 1 [supplemental materials are
available online only at http://jnm.snmjournals.org]). Syringes were filled with 18F-FDG at
concentrations of 2.5, 1.3, 0.63, and 0.31 MBq/mL, as measured by a well counter
(CRC-15R; Capintec). The phantom was centered in the PET FOVand imaged
simultaneously with PET/MRI 9 times over 2 h (PET: duration, 720 s; MRI: Fast Low
Angle SHot gradient echo (FLASH) repetition time/echo time, 500/4 ms; FOV, 35.4 × 35.4
mm; slice thickness, 0.75 mm; matrix size; 128 × 128; 40 slices). The phantom was rotated
90° clockwise about the long axis of the system between each scan to test for activity-
dependent differences in response among different regions of the reconstructed images.
Response homogeneity within PET images was measured with a hot-rod phantom
configured with the same geometry as the linearity phantom, except that all syringes
contained 1.5 MBq of 18F-FDG per milliliter. The hot-rod phantom was imaged 10 times
over 2 h (PET: 600 s) with a 90° clockwise rotation between consecutive scans. The first
linearity phantom scan of the study session was used to derive regression coefficients with
which other scans were calibrated; this method incorporated phantom-specific compensation
for attenuation, scatter, and partial-volume effects. A detailed description of the calibration
procedure is given in the supplemental data.
We also validated stability of the PET/MRI scanner over multiple imaging sessions.
Linearity phantoms were prepared and imaged as described for 3 separate imaging sessions
over 10 d. The coefficients of variation of calibration coefficients across sessions were
calculated.
Animal Studies
Animal studies were approved by the Animal Care and Use Committee at Caltech. Ten days
before imaging, TgCEA+C57BL/6 mice were implanted in the right flank with 8 × 105
MC-38.CEA (CEA, carcinoembryonic antigen) colorectal adenocarcinoma cells (18).
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18F-FDG—A tumor-bearing mouse was kept fasting for 4 h, injected intravenously with 37
MBq of 18F-FDG, and then warmed and sedated with a mixture of 1.5% isoflurane and air.
The injected activity was sufficient to allow imaging of the same mouse by PET/MRI,
small-animal PET, and QAR in the same study session. After 60 min, the mouse was
euthanized and secured to a cardboard platform; mouse and platform were placed on a
custom-designed plastic holder. The mouse was positioned with its long axis orthogonal to
the transaxial imaging planes of the PET/MRI scanner and imaged unfrozen with
simultaneous PET/MRI (PET: 600 s; MRI: Rapid Acquisition with Relaxation Enhancement
(RARE) repetition time/echo time, 3,500/4.5 ms; matrix size, 128 × 128; resolution, 0.28 ×
0.28 mm; slice thickness, 0.75 mm; 34 slices). After the initial PET/MRI scan, the mouse
was frozen in a dry-ice and isopropyl alcohol bath, repositioned into the holder, and
reimaged (PET: 1,200 s; MRI: RARE, same parameters as above). Using recorded prompts
counting rate and previous work relating prompts rate to true coincidence counting rate for
the PET/MRI scanner (15), we estimated the true-to-prompt coincidence event ratio for our
scans to be approximately 50%–75%.
To facilitate shielded transport between the laboratories at which PET/MRI and small-
animal PET/autoradiography experiments were done and cryosectioning for
autoradiography, the frozen mouse was cut to obtain a 3.5-cm-long section axially centered
on the tumor. A laser guide ensured that the cut face was orthogonal to the long axis of the
mouse. The section was positioned in an imaging holder parallel to the holder’s axis to
ensure that the cut face was orthogonal to the long axis of the microPET R4 scanner
(Concorde Microsystems) (19). The mouse section was then serially imaged with small-
animal PET and small-animal CT (Siemens InveonCT) (PET: 1,200 s, 350- to 650-keV
energy window, 6-ns timing window, and corrections made for detector normalization, dead
time, and random coincidence events, CT: 80 kVp, 500 μA, 200 ms/step, 361 steps covering
360°, 2 axial bed positions with a 20% overlap, voxels binned × 4). Measured true-to-
prompt event ratios in all small-animal PET scans were greater than 99%. Small-animal CT
images were reconstructed with the COBRA 3-dimensional reconstruction algorithm
(Exxim) to produce datasets with isotropic voxels (210 μm per side). Before reconstruction,
small-animal PET list-mode data were truncated to contain the same number of prompt
coincidence events as in the PET/MRI frozen-state scan. This was done in order to make
true count densities at least roughly comparable in the PET/MRI and small-animal PET
scans. Images were then reconstructed using 3-dimensional ordered-subset expectation
maximization MAP: 4 iterations, 12 subsets, followed by MAP: 30 iterations, β = 0.33,
optimized for uniform resolution).
After small-animal PET, the mouse section was embedded in a 4% carboxymethylcellulose
(Sigma-Aldrich) water mixture within a custom steel mold. The mold was placed in a dry-
ice and isopropyl alcohol bath for 10 min and then into a −20°C freezer for 1 h before being
mounted onto a cryomicrotome (Bright 5030/WD/MR; Hacker Instruments). Slices were
removed until tumor tissue was apparent. After that, 50-μm-thick transaxial frozen sections,
spaced 250 μm apart, were acquired for autoradiography until all tumor tissue had been
sectioned, ensuring at least 3 autoradiography slices per PET/MR image slice. During
sectioning, the block face was photographed (D70 camera [Nikon]; 90 mm 1:2:8 Macro φ55
lens [Tamra]). Sections were placed onto storage phosphor screens (Super Resolution
Screen; PerkinElmer). A 14C standard strip (Amersham) was placed on each screen for
calibration of screen sensitivity. Screens were exposed to collected sections for 3.5 d at
−20°C and then read with a laser scanner (Packard Cyclone).
64Cu-Labeled Antibody—Distribution of a radiolabeled antibody against CEA, 64Cu-
DOTA-NHS-M5A (9), was imaged in a tumor-bearing mouse. The antibody (5.6 MBq;
specific activity, 0.37 MBq/μg) was injected intravenously, and in vivo simultaneous PET/
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MRI was performed at 4 and 20 h after injection. The animal was kept at 35°C–37°C with a
warm air flow. At each time point, PET (3,600 s), anatomic MRI (RARE, same parameters
as listed above), and diffusion MR images (repetition time/echo time, 3,000/25 ms; matrix
size, 128 × 128; resolution, 0.28 × 0.28 mm; slice thickness, 0.75 mm; 10 slices, δ/Δ [where
δ is the duration of the diffusion gradient pulses and Δ the time between the pulses], 7/14
ms; b-values [b-factor describes the diffusion weighting of the pulses], 0, 300, and 1,000 s/
mm3; 1 direction) were acquired. The mouse was sacrificed 24 h after injection. Images
were then acquired with the PET/MRI scanner, small-animal PET, and autoradiography and
processed as per the 18F-FDG experiment.
Image Analysis
Image Coregistration—PET/MRI scanner images were aligned with MR images as
previously described (20). Images from nonfrozen and frozen specimens were aligned using
a rigid-body transformation obtained via landmarks along the anatomic contour. Small-
animal PETand small-animal CT images were coregistered with a rigid-body transformation
(Amira) using landmarks present on both images.
Autoradiography images acquired from different phosphor screens during the same study
session were cross-calibrated using 14C standard strips. For animal studies, slices within
each autoradiography and photography image z-stacks were first aligned across the stack
using the Fiji StackReg function (http://pacific.mpi-cbg.de/wiki/index.php/Fiji). The 2
stacks were then coregistered using a rigid-body transformation derived from 12 landmarks
per slice clearly seen on both stacks. Three adjacent slices falling within a given PET slice
were averaged to match the slice thickness of the PET/MRI scanner.
Before cross-modal registration, PET/MRI and autoradiography/photography datasets were
resliced to 1.2-mm thickness to match the slice thickness of reconstructed small-animal PET
images. Finally, PET/MRI and small-animal PET and small-animal CT image stacks were
aligned to the autoradiography/photography stack using a landmark-based rigid-body
algorithm implemented in Matlab (The Math-Works), resulting in a coregistered combined
dataset with voxel dimensions of 0.28 × 0.28 × 1.2 mm.
ROIs—For phantom images acquired in PET/MRI studies, cylindric volumes of interest
(VOIs) were axially centered within images of rods (diameter, 40% of the rod; length, 8.3
mm).
Tumor and whole-animal VOIs were drawn on photographic stacks using MRIcro (http://
www.MRIcro.com) and applied to PET and autoradiography images.
PET/Autoradiography Comparisons—Similarity metrics used to compare animal
images are summarized in Supplemental Table 1. Image intensities within VOIs were scaled
to fall between 0 and 1 for similarity analysis. We used scaled images because it was not
feasible to perform autoradiography of a linear calibration phantom during day-long animal
imaging experiments. Scaling was valid because phantom studies showed that the PET/MRI
scanner, small-animal PET, and autoradiography responses were linear (Supplemental Figs.
2 and 3).
In Vivo PET/Diffusion MRI—Aligned and calibrated (using a linearity phantom as
described in the supplemental data) PET/MRI scanner images were converted to units of
percentage injected dose per gram. Apparent diffusion coefficient (ADC) tumor maps were
generated from diffusion MRI data (6). Cooccurrence matrix analysis was used to compare
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ADC and PET images while taking into account the resolution differences between imaging
modalities. The cooccurrence matrix C was calculated using the following equation:
ADCr and PETr are ADC and PET images whose voxel values have been binned to 1 of 15
evenly spaced values lying within the intervals i ∈ [0, 1.5 × 10−3 mm2/s] and j ∈ [0.25 d,
0.75 d] (d is the maximum percentage injected dose per gram value in the VOI),
respectively. p, q, and r are voxel coordinates along x, y, and z directions of the n × m × l
image volume (defined by the VOI). a, b, and c are the PET voxel dimensions (0.28 × 0.28 ×
0.75 mm). The parameters |Δx|, |Δy| (≤1.5 mm), and |Δz| (≤2.1 mm) were equated to the
image resolution (average full width at half maximum [FWHM]) of the PET/MRI scanner
(15).
Statistical Analysis—Two-way ANOVA was used to compare image homogeneity and
linearity of PET/MRI scanner phantom data. Differences between rod intensities measured
from different quadrants of the image and individual rod intensities measured from separate
images during the study session were tested. Differences were considered significant when P
values were less than 0.05.
RESULTS
PET/MRI Scanner Response
Activity Concentration Recovery—Activity concentration recovery (ACR = measured
value/true value, measured value obtained from images using calibration coefficients
derived as described in supplemental data) from PET/MRI scanner phantom images are
shown in Figure 1. Linearity phantom images had ACRs close to unity (0.97 ± 0.06) for all
rods (diameter, 4 mm) across a 10-fold range of activity concentrations (Figs. 1A and 1B).
No significant difference in activity concentration recovery among spatial locations (P = 0.3)
or among different rod activity concentrations (P = 0.3) were observed. However,
reproducibility of the scanner-derived ACR was inversely related to rod activity
concentration (ACR SD, 23% for the lowest-activity-concentration rod, compared with 9%
for the highest-activity-concentration rod). This is likely because of increased noise in
reconstructed images at lower activity concentrations. Hot-rod phantom images also had
ACRs (1.03 ± 0.03) close to unity for a range of activities (Figs. 1C and 1D). Again, no
significant dependence of ACRs on spatial location (P = 0.5) or rod identity (P = 0.5) was
seen.
Stability Across Imaging Sessions—Calibration curves and regression coefficients
obtained with linearity phantoms from 3 separate imaging sessions over 10 d are shown in
Supplemental Figure 3. The data show that the PET/MRI scanner has a temporally stable
and linear response across a wide range of activity concentrations when system parameters
are kept constant.
Comparison of Image Intensity Patterns Across Modalities
Qualitative Assessments—Figure 2A shows coregistered images of a mouse injected
with 18F-FDG and imaged using PET/MRI, small-animal PET/CT, and autoradiography and
photography. As expected, 18F-FDG uptake in the tumor was elevated, compared with
surrounding tissues. The image intensity pattern was heterogeneous within the tumor and
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approximately congruent among all 3 imaging systems. Regions of high activity were
present in lateral and medial lobes of the tumor, with a region of lower activity in between.
The central region had somewhat higher relative intensity in autoradiography, compared
with PET images.
Images acquired 24 h after injection of 64Cu-DOTA-NHS-M5A are shown in Figure 2B.
Expected tumor localization of the antibody is observed, along with intratumoral
heterogeneity. The multilobed intratumoral uptake pattern is similar across PET/MRI, small-
animal PET, and autoradiography.
Quantitative Evaluation—Image similarity between different pairs of radioactivity
image sets was quantified using several metrics. Comparisons of the PET/MRI and
microPET R4 scanners with autoradiography are shown in Figures 3 and 4. Pixel-based
correlation coefficients for all PET-to- autoradiography comparisons were moderate to high
(>0.7) for both whole-mouse cross-sections and tumor ROIs (Figs. 3A and 3B). Not
surprisingly, correlation increased when autoradiography was blurred to match resolution to
the PET/MRI scanner and small-animal PET and dropped nearly to zero when the
autoradiography dataset was scrambled. An alternative pixel-based metric, peak signal-to-
noise ratio, gave similar results except that values were higher for whole-body than tumor
ROIs and the drop in metric value was less pronounced for a randomly scrambled image
(Figs. 3C and 3D).
Images were also analyzed with structure-based metrics (Fig. 4). Mean structural similarity
index (SSIM) and Complex Wavelet Structural Similarity Index (CWSSIM) analyses
showed no clear difference between PET/MRI and microPET R4 scanners. With both
measures, comparison of PET images for tumor ROIs generally showed higher in-termodal
similarity than did whole-body ROIs. When the autoradiography dataset was scrambled,
structure-based comparisons decreased to nearly zero, confirming that the metrics do reflect
image similarity. Similarity metrics obtained by comparing PET/MRI and small-animal PET
images with autoradiography were highly correlated (r ≥ 0.9).
Small differences shown by the metrics can be related to images. For example, comparison
of 18F-FDG data slightly favored the PET/MRI scanner over the small-animal PET scanner.
A possible explanation for this can be seen in Figure 2A, where PET/MRI of the frozen
specimen and QAR images show a more pronounced low-activity region between the 2 main
high-activity lobes and relatively flat dorsal tumor contours, compared with the small-
animal PET image. Differences among modalities are less pronounced in the antibody
images; this is seen in Figures 3B, 3D, 4B, and 4D, where on average data points lie closer
to the identity line than for 18F-FDG images. CWSSIM, a metric less sensitive to geometric
distortions than other metrics (21), attenuates these differences but also indicates improved
structural agreement between small-animal PET and blurred autoradiography images
of 64Cu in tumor, compared with PET/MRI.
Simultaneous In Vivo PET/MRI—Tumor uptake of 64Cu-DOTA-NHS-M5A at 4 and 20
h after injection is compared with simultaneously acquired MRI ADC images in Figure 5. At
4 h after injection, much of the antibody was still in the blood, as shown by the high signal
in the inferior vena cava (Fig. 5A) and low uptake within the ventral portion of the tumor. At
20 h, the antibody signal was spread throughout the tumor parenchyma (Fig. 5B).
Cooccurrence matrix analyses of the uptake pattern reflect these observations (Fig. 6). At 4
h, regions of relatively high antibody concentration within the tumor tended to be in regions
with high ADC values, suggesting that the antibodies were in the tumor’s intravascular or
interstitial spaces (Fig. 6A). By 20 h, this high uptake and high ADC cooccurrence
disappeared, suggesting uniform antibody distribution within the tumor (Fig. 6B).
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DISCUSSION
The feasibility of in vivo PET/MRI has been well demonstrated (4). However, it remains to
be shown that PET images from such a scanner accurately depict activity distribution within
the imaged tissue. Here, we demonstrated the ability of a MRI-compatible PET scanner (16)
to produce quantifiable intratumoral images that are stable, linear, and concordant with
images from a commercial small-animal PET scanner and autoradiography.
PET systems require a uniform and linear image intensity response. PET/MRI scanner–
derived images of linearity and hot-rod phantoms showed the system to be stable and linear
during a single imaging session and across multiple sessions. The linearity phantom allowed
us to demonstrate the stability of the PET/MRI system for measuring multiple activity
concentrations in the same image across multiple time-points within an imaging session.
These characteristics are crucial for successful dynamic simultaneous PET/MRI studies.
Activity concentration recovery in this study compares well with previous reports for small-
animal PET (22,23).
To quantitatively interpret and compare PET and QAR images, image intensities for both
modalities need to be linearly related to object activity concentration. To demonstrate that
PET and QAR imaging systems used in this study are linear and to confirm that our intended
strategy for animal studies is valid, we developed a gelatin phantom that could be visualized
by optical imaging, MRI, CT, PET, and QAR and assayed for radioactivity concentration by
γ-counting (Supplemental Fig. 1). Supplemental Figure 2 shows that image intensities
derived from phantoms were linearly related to sample activity concentration for all 3
imaging systems, enabling us to compare images from different systems with confidence.
The ability to return images with intensity patterns reflecting actual in vivo activity
distributions was compared among PET/MRI, small-animal PET, and QAR. Intratumoral
activity distributions for a metabolic marker (18F-FDG) and a targeted antibody were in
good overall spatial concordance among modalities. However, detailed examination of the
images revealed some differences. Resolution differences between autoradiography and PET
can be seen by the presence of finer structures in autoradiographs than in their PET
counterparts. For example, the antibody distribution in Figure 2B showed a small rim of
relatively high activity in the ventral portion of the tumor autoradiographs not visible with
PET. Christian et al. reported similar observations, attributing them to differences in
resolution between PET and autoradiography (24). Lack of attenuation and scatter correction
in PET/MRI scanner images may also contribute to disparities. Attenuation of 511-keV
photons can be as high as 15% with small-animal–sized objects (25). However, because
tumors imaged in our experiments were superficial, we expect attenuation-related
differences between PET and autoradiography to be minimal. Regardless of the limitations
of the imaging techniques used in this study, the intratumoral patterns are qualitatively
similar among PET/MRI, small-animal PET, and QAR for both 18F-FDG and the 64Cu-
antibody. Furthermore, similarity metrics showed good overall correlation between both
PET systems and QAR. Image differences between the 2 PET systems may be due to
resolution differences between the systems and, in case of the 18F-FDG study, high counting
rates during the PET/MRI scan compared with the small-animal PET.
The necessity and utility of detailed quantitative analyses are illustrated in Figure 5. Having
demonstrated good spatial fidelity of PET/MRI scanner images, we hypothesized that
biologic inferences can be made by comparing simultaneously acquired PET and MR
images. Fidelity of the PET images allowed us to conclude that there was a time-dependent
heterogeneous tumor accumulation of antibody during a preliminary study (Figs. 4 and 5).
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Previously, 2 methods have been used to compare multimodal intratumoral datasets. Cho et
al. performed a pixel-wise comparison of PET and dynamic contrast-enhanced MRI maps
(7), whereas Metz et al. used arbitrary thresholds to segment tumor subregions for
comparison (11). The former approach neglects differences in resolution between the
imaging modalities, whereas the latter requires multiple PET datasets and is observer-
dependent. We accounted for differences in resolution between PET and MRI by analyzing
image sets with a cooccurrence matrix bin offset equal to the mean FWHM of the scanner.
This analysis demonstrated spreading of antibody from a highly intravascular and
extracellular region throughout the tumor. There is recent interest in modeling tumor growth
kinetics using multimodal imaging datasets on a pixel-by-pixel basis (26). The cooccurrence
matrix method can be incorporated into these analyses to account for resolution differences
between the different modalities. Further improvements can be made to this method. For
instance, one can vary the FWHM window to account for varying spatial resolution within
the PET FOV.
To date, few studies have been published that evaluate PET image fidelity to actual in vivo
activity distributions. Christian et al. developed a Styrofoam (The Dow Chemical Co.)
holder surrounding a mouse to allow coregistered PET and autoradiography (27). Cho et al.
developed a foam mold and plastic holder for rat imaging (7). The current PET/MRI scanner
is not large enough to accommodate these solutions. Instead, landmarks visible on all
anatomic images (MRI, CT, photography) along with laser-guided positioning of the mice
allowed effective coregistration between PET and QAR.
It is remarkable that, despite limitations inherent in a first-generation prototype (e.g., low
sensitivity and lack of random coincidence or dead-time corrections), the current PET/MRI
scanner, operated simultaneously with MRI, provided PET images with spatial patterns
essentially equivalent to those of the well-established microPET R4 scanner. This
demonstrates the ability of the MRI-compatible PET scanner to deliver useful in vivo
information acquired simultaneously with MRI. Next-generation systems (28) will likely
improve on the quantitative ability and image quality of the current system. Methods
developed here can be used as a benchmark to assess the image quality of future systems.
Further, availability of good-fidelity, coregistered PET/MRI datasets and their QAR/
photography counterparts offers the opportunity to explore the biologic implications of
complementary imaging information and provide a test bed to develop and evaluate in vivo–
relevant PET partial-volume, motion-correction, and attenuation-correction algorithms.
CONCLUSION
We evaluated the ability of an MRI-compatible PET scanner to generate spatially and
quantitatively accurate images. Images acquired from tumor-bearing mice using different
radioisotopes showed good correspondence among PET/MRI, microPET R4 imaging, and
autoradiography. A cooccurrence matrix method enabling effective comparison of
complementary PET and MR images was presented. This work provides a basis for pursuing
biologically relevant simultaneous PET/MRI studies. Progress in hybrid PET/MRI
technology will provide improvements in image quality. Methods from this study can be
applied to evaluate such improvements.
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Refer to Web version on PubMed Central for supplementary material.
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FIGURE 1.
PET/MRI scanner accuracy and stability within imaging session. Measurements were made
on syringe rod phantoms described in “Materials and Methods” section. (A) ACR for 18F-
FDG linearity phantom images acquired over 2 h, with ROIs drawn over rods with varying
activity concentrations. No significant dependence on spatial location (P = 0.3) or activity
concentration (P = 0.3) was observed. (B) Rod ACRs, compared with actual rod activity
concentrations. (C) ACRs of 18F-FDG hot-rod phantom images acquired over 2 h, compared
with respect to spatial location and rod identity. No dependence on spatial location (P = 0.5)
or rod identity (P = 0.5) was observed. (D) Rod ACRs, compared with actual rod activities at
the time of imaging. All hot-rod syringes contained same activity concentration. Error bars
denote SD. BR = bottom right of image FOV; BL = bottom left of image FOV; TL = top left
of image FOV; TR = top right of image FOV.
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FIGURE 2.
Multimodal imaging of radio-tracer uptake in tumors. Mice bearing MC38.CEA tumors
were injected either with 18F-FDG (A) or anti-CEA 64Cu-DOTA-NHS-M5A antibody (B)
and sacrificed after uptake period. Tumor regions were then imaged with the PET/MRI
scanner, frozen, reimaged with PET/MRI, imaged in frozen state with small-animal PET and
small-animal CT, cryosectioned, and imaged with autoradiography. Matched tumor slices
show qualitatively similar uptake patterns. PET/MRI scanner images of 18F-FDG show hot
spot (circle) not observed with other modalities. Comparison with MRI showed hot spot to
be on animal’s surface, indicating that it was caused by urine residue, which was removed
before subsequent imaging (scale bar = 10 mm).
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FIGURE 3.
Pixel-based similarity across PET/MRI (frozen specimens), small-animal PET, and
autoradiography images. 18F-FDG and 64Cu-antibody coregistered datasets were compared
at whole-body and tumor ROI levels using correlation coefficients (A and B) and peak
signal-to-noise ratio (C and D). Similarity between each PET dataset and autoradiography
(with and without gaussian filter applied to autoradiography) was calculated and plotted
against each other. Control comparison between PET datasets and scrambled
autoradiography volume showed large decreases for correlation coefficient but not peak
signal-to-noise ratio. Pearson correlation coefficients comparing PET/MRI vs.
autoradiography and small-animal PET vs. autoradiography metrics are shown. Similarity
metrics are described in Supplemental Table 1.
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FIGURE 4.
Structure-based similarity among PET/MRI (frozen specimen), small-animal PET, and
autoradiography images. 18F-FDG and 64Cu-antibody coregistered datasets were at whole-
body and tumor ROI levels using SSIM (A and B) and CWSSIM (C and D). Pearson
correlation coefficients comparing PET/MRI vs. autoradiography and small-animal PET vs.
autoradiography metrics are shown.
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FIGURE 5.
In vivo simultaneous diffusion-MRI/radiolabeled antibody PET reveals phases of antibody
uptake. PET/MRI of mouse was obtained at 4 (A) and 20 (B) h after injection. Slices from 2
time points were matched as closely as possible. Both PET and diffusion MRI show
intratumoral heterogeneity of uptake and ADC values, respectively. General accumulation
of antibody was observed between 4 and 20 h. Focal distribution of antibody was observed
in more dorsal portion of tumor at 4 h after injection; by 20 h, distribution encompassed
most of tumor mass. Spatial patterning of ADC (shown only for tumor) was similar at both
time points. PET images were calibrated using linearity phantom as described in
supplemental data. Arrow points to inferior vena cava (scale bar = 10 mm).
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FIGURE 6.
Cooccurrence matrix analysis of functional PET and MRI data offers insight into tumor
antibody uptake. (A) Cooccurrence matrix comparing antibody uptake and ADC values at 4
h after injection. Uptake comparison window was adjusted to account for lower spatial
resolution of PET (1.5 mm in FWHM), compared with MRI. At 4 h, large fraction of
antibody signal colocalized with regions of high ADC (≥0.0015 mm2/s), suggesting much of
the antibody was in vascular or interstitial spaces. (B) By 20 h, that component had
disappeared; antibody was spread more evenly across tumor mass. This was not apparent
with pixel-by-pixel matching (Supplemental Fig. 4).
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